Oruka Therapeutics, Inc. Investing Cash Flow
Oruka Therapeutics, Inc. (ORKA) reported Investing Cash Flow of -$425.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$410.95M, a 8555.70% decline year-over-year.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$14.44M, a 133.68% decline year-over-year.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$22.02M.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$122.45M.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$96.75M.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$2.00K.
- Oruka Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2021 was -$43.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 11 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 114 month | Net Cash Provided by (Used in) Investing Activities 117 month | Net Cash Provided by (Used in) Investing Activities 120 month | Net Cash Provided by (Used in) Investing Activities 123 month | Net Cash Provided by (Used in) Investing Activities 126 month | Net Cash Provided by (Used in) Investing Activities 129 month | Net Cash Provided by (Used in) Investing Activities 132 month | Net Cash Provided by (Used in) Investing Activities 135 month | Net Cash Provided by (Used in) Investing Activities 138 month | Net Cash Provided by (Used in) Investing Activities 141 month | Net Cash Provided by (Used in) Investing Activities 144 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$410.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$425.38M 10-Q · filed 2026-08-10 | -$447.41M derived: sum of 3 quarters · filed 2026-08-10 | -$569.86M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2026-03-31 | -$14.44M 10-Q · filed 2026-05-13 | -$36.46M derived: sum of 2 quarters · filed 2026-05-13 | -$158.91M derived: sum of 3 quarters · filed 2026-05-13 | -$154.05M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-12-31 | -$22.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$144.47M derived: sum of 2 quarters · filed 2026-03-12 | -$139.61M derived: sum of 3 quarters · filed 2026-08-10 | -$96.75M 10-K · filed 2026-03-12 | |||||||||||||
| 2025-09-30 | -$122.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$117.59M derived: sum of 2 quarters · filed 2026-08-10 | -$74.72M 10-Q · filed 2025-11-12 | ||||||||||||||
| 2025-06-30 | $4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $47.73M 10-Q · filed 2026-08-10 | |||||||||||||||
| 2025-03-31 | $42.87M 10-Q · filed 2026-05-13 | ||||||||||||||||
| 2024-12-31 | -$330.13M 10-K · filed 2026-03-12 | ||||||||||||||||
| 2024-09-30 | -$171.00K 10-Q · filed 2025-11-12 | ||||||||||||||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | |||||||||||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 | ||||||||||||||||
| 2023-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||||||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2024-08-01 | $0.00 derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-25 | $0.00 derived: sum of 2 quarters · filed 2024-04-25 | $0.00 derived: sum of 3 quarters · filed 2024-04-25 | $0.00 derived: sum of 4 quarters · filed 2024-04-25 | |||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $0.00 derived: sum of 2 quarters · filed 2024-02-01 | $0.00 derived: sum of 3 quarters · filed 2024-02-01 | -$2.00K 10-K · filed 2024-02-01 | |||||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | $0.00 derived: sum of 2 quarters · filed 2023-10-18 | -$2.00K 10-Q · filed 2023-10-18 | -$9.00K derived: sum of 4 quarters · filed 2023-10-18 | |||||||||||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-21 | -$2.00K 10-Q · filed 2023-07-21 | -$9.00K derived: sum of 3 quarters · filed 2023-07-21 | -$23.00K derived: sum of 4 quarters · filed 2023-07-21 | |||||||||||||
| 2022-03-31 | -$2.00K 10-Q · filed 2023-04-24 | -$9.00K derived: sum of 2 quarters · filed 2023-04-24 | -$23.00K derived: sum of 3 quarters · filed 2023-04-24 | -$39.00K derived: sum of 4 quarters · filed 2023-04-24 | |||||||||||||
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$21.00K derived: sum of 2 quarters · filed 2023-02-24 | -$37.00K derived: sum of 3 quarters · filed 2023-02-24 | -$43.00K 10-K · filed 2023-02-24 | |||||||||||||
| 2021-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$30.00K derived: sum of 2 quarters · filed 2022-10-28 | -$36.00K 10-Q · filed 2022-10-28 | -$49.00K derived: sum of 4 quarters · filed 2022-10-28 | |||||||||||||
| 2021-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$22.00K 10-Q · filed 2022-08-02 | -$35.00K derived: sum of 3 quarters · filed 2022-08-02 | -$35.00K derived: sum of 4 quarters · filed 2022-08-02 | |||||||||||||
| 2021-03-31 | -$6.00K 10-Q · filed 2022-05-02 | -$19.00K derived: sum of 2 quarters · filed 2022-05-02 | -$19.00K derived: sum of 3 quarters · filed 2022-05-02 | -$22.00K derived: sum of 4 quarters · filed 2022-05-02 | |||||||||||||
| 2020-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$13.00K derived: sum of 2 quarters · filed 2022-03-14 | -$16.00K derived: sum of 3 quarters · filed 2022-03-14 | -$19.00K 10-K · filed 2022-03-14 | |||||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$3.00K derived: sum of 2 quarters · filed 2021-11-02 | -$6.00K 10-Q · filed 2021-11-02 | -$8.00K derived: sum of 4 quarters · filed 2021-11-02 | |||||||||||||
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$6.00K 10-Q · filed 2021-08-04 | -$8.00K derived: sum of 3 quarters · filed 2021-08-04 | ||||||||||||||
| 2020-03-31 | -$3.00K 10-Q · filed 2021-05-11 | -$5.00K derived: sum of 2 quarters · filed 2021-05-11 | |||||||||||||||
| 2019-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$4.00K 10-K · filed 2021-03-18 | |||||||||||||||
| 2019-09-30 | -$2.00K 10-Q · filed 2020-11-02 | ||||||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$3.00K derived: sum of 2 quarters · filed 2020-02-18 | -$3.00K derived: sum of 3 quarters · filed 2020-02-18 | $3.05M 10-K · filed 2020-02-18 | |||||||||||||
| 2018-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$3.00K derived: sum of 2 quarters · filed 2019-11-06 | $3.05M 10-Q · filed 2019-11-06 | $7.79M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $3.05M 10-Q · filed 2019-08-01 | $7.80M derived: sum of 3 quarters · filed 2019-08-01 | $6.87M derived: sum of 4 quarters · filed 2019-08-01 | |||||||||||||
| 2018-03-31 | $3.05M 10-Q · filed 2019-05-08 | $7.80M derived: sum of 2 quarters · filed 2019-05-08 | $6.87M derived: sum of 3 quarters · filed 2019-05-08 | ||||||||||||||
| 2017-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $3.82M derived: sum of 2 quarters · filed 2019-02-27 | $12.93M 10-K · filed 2019-02-27 | ||||||||||||||
| 2017-09-30 | -$932.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $8.18M 10-Q · filed 2018-11-14 | |||||||||||||||
| 2017-06-30 | $9.11M 10-Q · filed 2018-08-09 | ||||||||||||||||
| 2013-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$15.00K derived: sum of 2 quarters · filed 2014-03-20 | -$23.00K derived: sum of 3 quarters · filed 2014-03-20 | -$32.00K 10-K · filed 2014-03-20 | $45.02M 10-K · filed 2014-03-20 | ||||||||||||
| 2013-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$19.00K derived: sum of 2 quarters · filed 2013-11-13 | -$28.00K 10-Q · filed 2013-11-13 | -$27.00K derived: sum of 4 quarters · filed 2013-11-13 | $45.03M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$17.00K 10-Q · filed 2013-08-13 | -$16.00K derived: sum of 3 quarters · filed 2013-08-13 | -$16.00K derived: sum of 4 quarters · filed 2013-11-13 | $45.04M 10-Q · filed 2013-08-13 | ||||||||||||
| 2013-03-31 | -$9.00K 10-Q · filed 2013-05-13 | -$8.00K derived: sum of 2 quarters · filed 2013-05-13 | -$8.00K derived: sum of 3 quarters · filed 2013-11-13 | -$9.00K derived: sum of 4 quarters · filed 2013-11-13 | $45.05M 10-Q · filed 2013-05-13 | ||||||||||||
| 2012-12-31 | $1.00K derived: 10-K 132 month − 10-Q 129 month · filed 2013-03-21 | $1.00K derived: sum of 2 quarters · filed 2013-11-13 | $0.00 derived: sum of 3 quarters · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 | $45.05M 10-K · filed 2013-03-21 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$1.00K derived: sum of 2 quarters · filed 2013-11-13 | -$1.00K 10-Q · filed 2013-11-13 | $4.00K derived: sum of 4 quarters · filed 2013-11-13 | $45.05M 10-Q · filed 2012-11-13 | ||||||||||||
| 2012-06-30 | -$1.00K derived: 10-Q 126 month − 10-Q 123 month · filed 2012-08-13 | -$1.00K 10-Q · filed 2013-08-13 | $4.00K derived: sum of 3 quarters · filed 2013-03-21 | $5.00K derived: sum of 4 quarters · filed 2013-03-21 | $45.05M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 123 month − 10-K 120 month · filed 2012-05-14 | $5.00K derived: sum of 2 quarters · filed 2013-03-21 | $6.00K derived: sum of 3 quarters · filed 2013-03-21 | $45.05M 10-Q · filed 2012-05-14 | |||||||||||||
| 2011-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $6.00K derived: sum of 2 quarters · filed 2013-03-21 | $2.01M 10-K · filed 2013-03-21 | $45.05M 10-K · filed 2012-03-27 | |||||||||||||
| 2011-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $2.00M 10-Q · filed 2012-11-13 | $45.05M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $2.00M 10-Q · filed 2012-08-13 | $45.05M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2010-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $261.00K derived: sum of 2 quarters · filed 2012-03-27 | $265.00K 10-K · filed 2012-03-27 | ||||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $4.00K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | $4.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |